mitoxantrone has been researched along with Oligohydramnios in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Oligohydramnios: A condition of abnormally low AMNIOTIC FLUID volume. Principal causes include malformations of fetal URINARY TRACT; FETAL GROWTH RETARDATION; GESTATIONAL HYPERTENSION; nicotine poisoning; and PROLONGED PREGNANCY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mitoxantrone is an antineoplastic agent considered a potential human teratogen because of its mechanism of action and is classified by the US Food and Drug Administration in pregnancy category risk D." | 7.74 | The first case of mitoxantrone exposure in early pregnancy. ( Batocchi, AP; Caruso, A; Cavaliere, AF; De Santis, M; Rosati, P; Straface, G, 2007) |
| "Mitoxantrone is an antineoplastic agent considered a potential human teratogen because of its mechanism of action and is classified by the US Food and Drug Administration in pregnancy category risk D." | 3.74 | The first case of mitoxantrone exposure in early pregnancy. ( Batocchi, AP; Caruso, A; Cavaliere, AF; De Santis, M; Rosati, P; Straface, G, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Santis, M | 1 |
| Straface, G | 1 |
| Cavaliere, AF | 1 |
| Rosati, P | 1 |
| Batocchi, AP | 1 |
| Caruso, A | 1 |
1 other study available for mitoxantrone and Oligohydramnios
| Article | Year |
|---|---|
The first case of mitoxantrone exposure in early pregnancy.
Topics: Adult; Analgesics; Apgar Score; Female; Fetal Growth Retardation; Humans; Magnetic Resonance Imaging | 2007 |